Find Progesterone Injection, Female Protection, Finished Medicine on Industry Directory, Reliable Manufacturer/Supplier/Factory from China.

Inquiry Basket (0)
Home > Products > Medical Antibiotics > GMP Standard Antibiotic Amikacin Injection for Infections

GMP Standard Antibiotic Amikacin Injection for Infections

Basic Info

Model No.:  HEA371829M

Product Description

Model NO.: HEA371829M Usage Mode: For external use State: Liquid Type: Biological Products Name: Amikacin Sulfate Injection Sample: Acceptable Port: Guangzhou Shelf Life: 36 Months Transport Package: 1 Vial/Bottle Origin: France Application: Internal Medicine Suitable for: Elderly, Children, Adult Shape: Vial Pharmaceutical Technology: Chemical Synthesis Composition: Beta-Lactam MOQ: 1 Box Delivery Time: 7 Days Trademark: GUYENNE Specification: 100mg/2ml HS Code: 3004909090 Amikacin Sulfate Injection Hospital-acquired Treating
 
Specification Package
100mg/2ml 1vial/box
500mg/2ml 1vial/box


Amikacin, sold under the brandname Amikin, is an aminoglycoside antibiotic used to treat different types of bacterial infections. Amikacin works by binding to the bacterial 30S ribosomal subunit, causing misreading of mRNA and leaving the bacterium unable to synthesize proteins vital to its growth.

Amikacin was initially sold in 1976. It is on the World Health Organization's List of Essential Medicines, a list of the most important medication needed in a basic health system.

Amikacin is most often used for treating severe, hospital-acquired infections with multidrug-resistant Gram-negative bacteria such as Pseudomonas aeruginosa, Acinetobacter, and Enterobacter. Serratia marcescens and Providencia stuartii are also included in the spectrum. Amikacin can also be used to treat non-tubercular mycobacterial infections and tuberculosis (if caused by sensitive strains) when first-line drugs fail to control the infection.

Amikacin may be combined with a beta-lactam antibiotic for empiric therapy for people with neutropenia and fever.

Liposomal amikacin for inhalation is currently in late stage clinical trials for the treatment of respiratory diseases, such as cystic fibrosis, Pseudomonas aeruginosa, non-tubercular mycobacterial infections and bronchiectasis.

Contact us if you need more details on Amikacin. We are ready to answer your questions on packaging, logistics, certification or any other aspects about Antibiotic、Amikin. If these products fail to match your need, please contact us and we would like to provide relevant information.

Product Categories : Medical Antibiotics